Back to today’s briefing

Story perspectives

Signify Bio Raises $15 Million for Protein Therapeutics

6/7/2025

39 4

Summary

Story summary

Signify Bio, a Dallas-based biotech startup, has successfully secured $15 million in an oversubscribed financing round, spearheaded by Actium Group and backed by prominent investors, including the Gates Foundation. Co-founders Daniel J. Siegwart and RA Session II are on a mission to revolutionize medicine with personalized protein therapeutics, leveraging cutting-edge technologies from their collaboration with UT Southwestern.

1 of 1

Story summary

Signify Bio, a Dallas-based biotech startup, has successfully secured $15 million in an oversubscribed financing round, spearheaded by Actium Group and backed by prominent investors, including the Gates Foundation. Co-founders Daniel J. Siegwart and RA Session II are on a mission to revolutionize medicine with personalized protein therapeutics, leveraging cutting-edge technologies from their collaboration with UT Southwestern.